ITMO Santé Publique
ITMO Santé Publique
Date de modification : 05/05/2021 | Version : 1 | ID : 73909
| Général | |
| Identification | |
| Nom détaillé | Study on the implementation of the revised HOME-CoV score to guide the choice of hospitalisation or outpatient management of patients with confirmed or probable SARS-CoV-2 infection admitted to an emergency department. |
| Sigle ou acronyme | Revised HOME-CoV |
| Numéro d'enregistrement (ID-RCB ou EUDRACT, CNIL, CPP, etc.) | 2020-A03067-32 |
| Thématiques générales | |
| Domaine médical |
Emergency medicine |
| Etude en lien avec la Covid-19 |
Yes |
| Déterminants de santé |
Healthcare system and access to health care services |
| Responsable(s) scientifique(s) | |
| Nom du responsable | Douillet |
| Prénom | Delphine |
| Adresse | Departement de Médecine d'Urgence<br>4 rue Larrey<br>CHU ANGERS |
| Delphine.Douillet@chu-angers.fr | |
| Collaborations | |
| Financements | |
| Financements |
Public |
| Précisions | Angers University Hospital |
| Gouvernance de la base de données | |
| Organisation(s) responsable(s) ou promoteur | Angers University Hospital |
| Statut de l’organisation | |
| Contact(s) supplémentaire(s) | |
| Caractéristiques | |
| Type de base de données | |
| Type de base de données |
Study databases |
| Base de données issues d'enquêtes, précisions |
Cohort study |
| Origine du recrutement des participants |
A selection of health institutions and services |
| Critère de sélection des participants |
Another treatment or procedure |
| Le recrutement dans la base de données s'effectue dans le cadre d'une étude interventionnelle |
Yes |
| Précisions |
Performed at group level (clusters) |
| Objectif de la base de données | |
| Objectif principal |
The primary objective is to demonstrate the reliability and safety of outpatient management among patients highly suspected or confirmed as infected with COVID-19, attending an emergency department and with a revised HOME-CoV score less than 2 (negative rule).
The secondary objectives are as follows: i. Evaluate the rate of patients having required hospitalisation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule. ii. Evaluate the rate of patients having required hospitalisation and initiation of oxygen therapy within 7 days following inclusion according to the revised positive or negative HOME-CoV rule. iii. Evaluate the rate of patients having required intubation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule. iv. Evaluate the rate of all-cause deaths within 7 days following inclusion according to the revised positive or negative HOME-CoV rule. v. Evaluate the performance of the revised HOME-CoV score in predicting a negative outcome in the patient subgroup with SARS-CoV-2 infection confirmed by RT-PCR to rule out the risk of a negative outcome when assessed as low risk. vi. Compare the performance of the revised HOME-CoV score with that of other existing scores. |
| Critères d'inclusion |
Adult patient (> 18 years),
- Attending one of the emergency departments taking part in the study due to COVID-19 infection confirmed by SARS-CoV-2 positive RT-PCR, or considered highly probable by the physician managing the patient, - Not requiring management in a continuous care or intensive care unit, and subject to a decision to limit active treatment, - Having given their formal consent to take part in the study, - Registered with or a beneficiary of a social security scheme. |
| Type de population | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population concernée |
Sick population |
| Pathologie | B33 - Other viral diseases, not elsewhere classified |
| Sexe |
Male Woman |
| Champ géographique |
International |
| Détail du champ géographique | France Belgium |
| Collecte | |
| Dates | |
| Taille de la base de données | |
| Taille de la base de données (en nombre d'individus) |
[1000-10 000[ individuals |
| Détail du nombre d'individus | 1,300 patients |
| Données | |
| Activité de la base |
Current data collection |
| Type de données recueillies |
Clinical data Declarative data Paraclinical data Biological data Administrative data |
| Données cliniques, précisions |
Direct physical measures Medical registration |
| Données déclaratives, précisions |
Face to face interview |
| Modalités | |
| Pathologie suivies | |
| Valorisation et accès | |
| Valorisation et accès | |
| Accès |
| A PROPOS | CATALOGUE | RESSOURCES | LIENS UTILES
|  Ce site respecte les principes de la charte HONcode. Vérifiez ici. |
8 rue de la Croix Jarry 75013 Paris Tél: 01 44 23 67 47 |
Partenaires - F.A.Q. - Contact - Plan du site - Mentions légales - Administration - PEF-HD - Mis à jour le 15 décembre 2020 - Version 4.10.05
